In the first half of 2022, the Swiss company Roche yielded over 13 percent of the total oncology drug revenue acquired via public procurement in Russia. The Russian company Biocad closely followed, with a share of 11 percent. The total revenue earned by manufacturers from cancer drug sales in Russia was estimated at 1.1 billion U.S. dollars in 2022.
Share of total oncology drug revenue earned from public procurement in Russia in 1st half 2022, by leading manufacturer
Characteristic
Share of total oncology drug revenue
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Exclusive Premium Statistic
To access all Premium Statistics, you need a paid Statista Account
Public procurement is a process by which a government purchases goods from the private sector to meet state and municipal needs whilst paying from budgetary or non-budgetary funds.
Only the 10 leading pharmaceutical companies are presented.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Vmeste Protiv Raka. (August 4, 2022). Share of total oncology drug revenue earned from public procurement in Russia in 1st half 2022, by leading manufacturer [Graph]. In Statista. Retrieved July 22, 2024, from https://www.statista.com/statistics/1385977/russia-top-pharma-companies-by-oncology-revenue-share/
Vmeste Protiv Raka. "Share of total oncology drug revenue earned from public procurement in Russia in 1st half 2022, by leading manufacturer." Chart. August 4, 2022. Statista. Accessed July 22, 2024. https://www.statista.com/statistics/1385977/russia-top-pharma-companies-by-oncology-revenue-share/
Vmeste Protiv Raka. (2022). Share of total oncology drug revenue earned from public procurement in Russia in 1st half 2022, by leading manufacturer. Statista. Statista Inc.. Accessed: July 22, 2024. https://www.statista.com/statistics/1385977/russia-top-pharma-companies-by-oncology-revenue-share/
Vmeste Protiv Raka. "Share of Total Oncology Drug Revenue Earned from Public Procurement in Russia in 1st Half 2022, by Leading Manufacturer." Statista, Statista Inc., 4 Aug 2022, https://www.statista.com/statistics/1385977/russia-top-pharma-companies-by-oncology-revenue-share/
Vmeste Protiv Raka, Share of total oncology drug revenue earned from public procurement in Russia in 1st half 2022, by leading manufacturer Statista, https://www.statista.com/statistics/1385977/russia-top-pharma-companies-by-oncology-revenue-share/ (last visited July 22, 2024)
Share of total oncology drug revenue earned from public procurement in Russia in 1st half 2022, by leading manufacturer [Graph], Vmeste Protiv Raka, August 4, 2022. [Online]. Available: https://www.statista.com/statistics/1385977/russia-top-pharma-companies-by-oncology-revenue-share/